BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7196368)

  • 1. The diurnal variations of glutamic acid decarboxylase activity in some discrete nuclei of rat brain.
    Kawahara R; Hazama H; Kamase H; Takeshita H; Kunimoto N; Kayano M
    Folia Psychiatr Neurol Jpn; 1980; 34(4):473-9. PubMed ID: 7196368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamic acid decarboxylase (GAD) activity in the rat substantia nigra after discrete bilateral kainic acid-induced lesions of the caudate-putamen and globus pallidus: correlation with locomotor activity.
    Al-Shabibi UM; Davies JA
    Brain Res; 1981 Jun; 213(2):460-6. PubMed ID: 7248771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The distribution and origin of glutamate decarboxylase and choline acetyltransferase in ventral pallidum and other basal forebrain regions.
    Walaas I; Fonnum F
    Brain Res; 1979 Nov; 177(2):325-36. PubMed ID: 497834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional differences in cofactor saturation of glutamate decarboxylase (GAD) in discrete brain nuclei of the rat. Effect of repeated administration of haloperidol on GAD activity in the substantia nigra.
    Itoh M; Uchimura H
    Neurochem Res; 1981 Dec; 6(12):1283-9. PubMed ID: 7339506
    [No Abstract]   [Full Text] [Related]  

  • 5. A striatal source of glutamic acid decarboxylase activity in the substantia nigra.
    Nagy JI; Fibiger HC
    Brain Res; 1980 Apr; 187(1):237-42. PubMed ID: 7357470
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of discrete kainic acid-induced lesions of corpus caudatus and globus pallidus on glutamic acid decarboxylase of rat substantia nigra.
    Di Chiara G; Morelli M; Porceddu ML; Mulas M; Del Fiacco M
    Brain Res; 1980 May; 189(1):193-208. PubMed ID: 7363085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origin and distribution of glutamate decarboxylase in the nucleus subthalamicus of the cat.
    Fonnum F; Grofavá I; Rinvik E
    Brain Res; 1978 Sep; 153(2):370-4. PubMed ID: 687988
    [No Abstract]   [Full Text] [Related]  

  • 8. Distribution of glutamate decarboxylase in discrete brain nuclei.
    Tappaz ML; Brownstein MJ; Palkovits M
    Brain Res; 1976 May; 108(2):371-9. PubMed ID: 1276902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered neurotransmitter synthetic enzyme activity in some extrapyramidal nuclei after lesions of the nigro-striatal dopamine projection.
    Nagy JI; Vincent SR; Fibiger HC
    Life Sci; 1978 May; 22(20):1777-82. PubMed ID: 672427
    [No Abstract]   [Full Text] [Related]  

  • 10. Glutamate decarboxylase distribution in discrete motor nuclei in the cat brain.
    Nieoullon A; Dusticier N
    J Neurochem; 1981 Jul; 37(1):202-9. PubMed ID: 7252505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of haloperidol on glutamate decarboxylase activity in discrete brain areas of the rat.
    Itoh M
    Psychopharmacology (Berl); 1983; 79(2-3):169-72. PubMed ID: 6405424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of different doses of apomorphine on the glutamate decarboxylase activity of the substantia nigra and the medial basal hypothalamus].
    Giammona G; PattĂ­ F; Sambataro V; Reggio A; Rampello L; Di Giorgio RM; Maccagnano C; Condorelli DF; Nicoletti F
    Boll Soc Ital Biol Sper; 1981 Oct; 57(20):2074-9. PubMed ID: 7317201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The GABA neurons and their axon terminals in rat corpus striatum as demonstrated by GAD immunocytochemistry.
    Ribak CE; Vaughn JE; Roberts E
    J Comp Neurol; 1979 Sep; 187(2):261-83. PubMed ID: 226567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the origin of substance P and glutamic acid decarboxylase (GAD) in the substantia nigra.
    Brownstein MJ; Mroz EA; Tappaz ML; Leeman SE
    Brain Res; 1977 Oct; 135(2):315-23. PubMed ID: 922480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of L-glutamic acid decarboxylase in different regions of baboon brain.
    Kataoka K; Nakamura Y; Hassler R; Bak IJ; Kim JS
    Folia Psychiatr Neurol Jpn; 1975; 29(4):361-70. PubMed ID: 821834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease of glutamate decarboxylase (GAD)-immunoreactive nerve terminals in the substantia nigra after kainic acid lesion of the striatum.
    Oertel WH; Schmechel DE; Brownstein MJ; Tappaz ML; Ransom DH; Kopin IJ
    J Histochem Cytochem; 1981 Aug; 29(8):977-80. PubMed ID: 7024401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-glutamic acid decarboxylase in Parkinson's disease: effect of L-dopa therapy.
    Lloyd KG; Hornykiewicz O
    Nature; 1973 Jun; 243(5409):521-3. PubMed ID: 4743649
    [No Abstract]   [Full Text] [Related]  

  • 18. GABAergic nerve terminals decrease in the substantia nigra following hemitransections of the striatonigral and pallidonigral pathways.
    Ribak CE; Vaughn JE; Roberts E
    Brain Res; 1980 Jun; 192(2):413-20. PubMed ID: 7378797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Origin of glutamate-decarboxylase (GAD)-containing cells in discrete hypothalamic nuclei.
    Tappaz ML; Brownstein MJ
    Brain Res; 1977 Aug; 132(1):95-106. PubMed ID: 302137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of messenger RNAs for glutamic acid decarboxylase, preprotachykinin, cholecystokinin, somatostatin, proenkephalin and neuropeptide Y in the adult rat superior colliculus.
    Harvey AR; Heavens RP; Yellachich LA; Sirinathsinghji DJ
    Neuroscience; 2001; 103(2):443-55. PubMed ID: 11246159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.